B. Riley Wealth Advisors Inc. Increases Stock Holdings in Aspira Women’s Health Inc. (NASDAQ:AWH)

B. Riley Wealth Advisors Inc. raised its holdings in Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 316,294 shares of the company’s stock after buying an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc. owned about 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent reporting period.

Separately, Pine Valley Investments Ltd Liability Co purchased a new position in Aspira Women’s Health in the 3rd quarter worth $25,000. Institutional investors and hedge funds own 12.19% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on Aspira Women’s Health in a research note on Thursday. They set a “hold” rating on the stock.

Aspira Women’s Health Price Performance

NASDAQ:AWH opened at $0.77 on Friday. The company’s fifty day moving average price is $0.82 and its 200-day moving average price is $1.08. Aspira Women’s Health Inc. has a 1-year low of $0.67 and a 1-year high of $5.65. The firm has a market capitalization of $12.83 million, a P/E ratio of -0.64 and a beta of 1.39.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.